Pancreatic cancer is one of the deadliest types of cancer, with fewer than 13% of people diagnosed with it surviving for more ...

Neil Vaccines are medicine which protect the human body by making it immune from a certain disease. Now, there’s been a ...

点击蓝字关注我们【导读】癌症疫苗面临的一个基本挑战，是如何产生对肿瘤抗原具有特异性的长效功能性T细胞。在这项研究中，团队发现针对体细胞突变衍生的新抗原的mRNA脂质体疫苗，可以解决胰腺导管腺癌（PDAC）的这一难题。2025年2月19日，美国纪念斯隆 ...

Personalized mRNA vaccines show promise as a pancreatic cancer treatment, according to a small, early stage trial published ...

A Memorial Sloan Kettering phase 1 clinical trial revealed an immune response in some pancreatic cancer patients. Study ...

There is new hope in the fight against pancreatic cancer after early trials showed that personalized mRNA vaccines can target ...

A clinical trial from Memorial Sloan Kettering Cancer Center looked at the effects of a targeted mRNA vaccine on early-stage ...

Songwriter and music teacher Steve Young of Stevenage, Hertfordshire, made global news as one of the first people to be given ...

在癌症治疗的战场上，疫苗一直被寄予厚望，它就像一位英勇的战士，肩负着对抗癌症的重任。然而，现实却给这位战士设置了重重障碍。其中一个最棘手的问题就是，如何让癌症疫苗产生长期存活且功能强大的 T 细胞（一种在免疫系统中发挥关键作用的白细胞，能识别和攻击异常细胞），而且这些 T 细胞还得精准地针对肿瘤抗原。这就好比要训练出一批神枪手，不仅要百发百中，还得能长时间坚守岗位。

A promising new mRNA-based vaccine for pancreatic cancer has shown potential in reducing the recurrence of the disease ...

In a small trial, 8 of 16 patients responded well to the mRNA vaccine The vaccine is personalized, based on each patient’s ...

A personalized mRNA vaccine appeared to reduce the chances of pancreatic cancer returning after surgery, according to a study ...